SCHEMBL3633555

SCHEMBL3633555

COc1ccc(C(=O)N2CCN(c3cnc4ccc(-c5cncc(-c6ccccc6S(N)(=O)=O)c5)cc4n3)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.44
F10 P00742 2/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CA7 P43166 1/20 0.43
CA14 Q9ULX7 1/20 0.43
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
CCKAR P32238 5/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629011 0.86 GBA1 (0.44) F10ALDH1A1SMN1; SMN2NPC1MAPT
SCHEMBL3634324 0.85 PIK3CA (0.43) F10ALDH1A1SMN1; SMN2NPC1MAPT
SCHEMBL3629695 0.82 MAPT (0.44) F10ALDH1A1SMN1; SMN2NPC1MAPT
SCHEMBL3635713 0.81 HCRTR1 (0.51) CA12CA1CA2CA9ALDH1A1
SCHEMBL3085564 0.81 LMNA (0.56) SLC6A7ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL3627322 0.77 F10 (0.39) F10MEN1KMT2A
SCHEMBL3630265 0.77 F10 (0.37) F10ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL3087886 0.75 ALDH1A1 (0.55) CA12CA1CA2CA9CA7
SCHEMBL3630355 0.75 PIK3CB (0.39) F10CA12CA1CA2CA9
SCHEMBL3627366 0.73 SMO (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150255-A1 QUINOXALINE DERIVATIVES AS P13 KINASE INHIBITORS Smithkline Beecham Corporation (US) 2010-02-10 EP disclosed
WO-2008141065-A1 QUINOXALINE DERIVATIVES AS P13 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-11-20 WO disclosed